TB Online is no longer maintained. This is an archive of the site. For news on TB please go to: https://globaltbcab.org/

News

Brief news reports on Tuberculosis

Complex impacts of genotype, child weight on efavirenz with anti-TB therapy

CYP2B6 genotype was a stronger predictor of efavirenz concentrations than rifampicin-based anti-TB therapy in South African children, according to results of a three-way comparison. The researchers believe their findings do not support higher efavirenz doses in children taking rifampicin.

Read More →

Tuberculosis and Parkinson’s disease linked by unique protein

A protein at the center of Parkinson’s disease research now also has been found to play a key role in causing the destruction of bacteria that cause tuberculosis, according to a UC San Francisco-led research team.

Read More →

Stop TB Partnership to host meeting for all partners during 2013 World Conference on Lung Health

04 September 2013 - Geneva - The Stop TB Partnership will host a meeting on 31 October 2013 for all partners and other people who are visiting Paris for the World Conference on Lung Health.

Read More →

GlobeImmune awarded $4 million NIH grant to develop Tarmogens for the treatment of tuberculosis

LOUISVILLE, Colo., September 4, 2013 – GlobeImmune, Inc., announced today that it has been awarded a $4 million Research Project Grant (R01) by the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) to support the development of Tarmogen® immunotherapy products to treat and prevent tuberculosis infection.

Read More →

Home treatment helps South African miners beat tuberculosis

South African mine workers have always lived in mortal fear of tuberculosis. They saw miners disappearing into grim hospitals and never returning. It was seen as the end of life.

Read More →

Imaxio announces the first human clinical trial using its pro-immunogenic technology IMX313, in tuberculosis

IMX313, Imaxio’s antigen re-engineering technology, has been administrated for the first time in humans as part of a tuberculosis vaccine phase I clinical trial managed by the Jenner Institute at Oxford University.

Read More →

Programmatically selected multidrug-resistant strains drive the emergence of extensively drug-resistant tuberculosis in South Africa

Abstract

Read More →

Two diseases, one patient…

Tuberculosis (TB) and Human Immunodeficiency Virus (HIV) – can we continue to tackle these separately? According to the Global TB Report (2012), in 2011, out of 8.7 million people who developed TB worldwide 1.1 million (13%) were HIV positive. An approximate of 0.4 million HIV-associated TB deaths took place in 2011 and TB is the most common opportunistic infection among people living with HIV (PLWH).  HIV increases chances that latent TB infection can become active TB disease and also increases the risk of death due to this.

Read More →

South Korea: Nearly 40,000 newly infected with TB in 2012

Korea recorded 40,000 new cases of tuberculosis (TB) infections last year, a government report showed Sunday, hinting the country still needs more attention on the disease usually found in developing countries.

Read More →

A disease as old as humanity itself: How TB took over the world

Perhaps no other disease has had such a dramatic influence on art, music and literature. Now science has shown that tuberculosis is as old as humanity itself.

Read More →

Page 722 of 895 · Total posts: 10

←First 721 722 723 Last→